Dr. Eric Schmidt discusses the rapid convergence of AI and biotechnology, highlighting AI's potential to accelerate drug discovery while also posing significant risks. He warns that AI is underhyped, predicting the imminent arrival of AGI and detailing the intense geopolitical competition with China.